Bonnie W Ramsey Selected Research

denufosol tetrasodium

3/2011	Denufosol tetrasodium in patients with cystic fibrosis and normal to mildly impaired lung function.
8/2007	Phase 2 randomized safety and efficacy trial of nebulized denufosol tetrasodium in cystic fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bonnie W Ramsey Research Topics

Disease

45	Cystic Fibrosis (Mucoviscidosis) 11/2022 - 07/2002
16	Infections 01/2021 - 07/2002
8	Inflammation (Inflammations) 11/2022 - 10/2003
7	Pseudomonas Infections 01/2022 - 10/2003
6	Lung Diseases (Lung Disease) 08/2013 - 10/2003
2	Respiratory Tract Infections (Respiratory Tract Infection) 11/2016 - 03/2014
2	Rare Diseases (Rare Disease) 08/2014 - 08/2007
2	Persistent Infection 12/2006 - 05/2006
1	Weight Gain 01/2022
1	Pain (Aches) 01/2018
1	Meconium Ileus 01/2017
1	Exocrine Pancreatic Insufficiency 01/2017
1	Chronic Obstructive Pulmonary Disease (COPD) 03/2014
1	Bronchiectasis 03/2014
1	Ventilator-Associated Pneumonia 03/2014
1	Coinfection 08/2013
1	Airway Obstruction (Choking) 01/2013
1	Exanthema (Rash) 11/2010
1	Reinfection 11/2003

Drug/Important Bio-Agent (IBA)

13	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2021 - 10/2003
11	ivacaftorIBA 11/2019 - 11/2010
9	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 07/2002
7	ChloridesIBA 01/2021 - 03/2011
5	elexacaftorIBA 01/2021 - 10/2018
5	ivacaftor drug combination tezacaftorIBA 01/2021 - 10/2018
5	Pharmaceutical PreparationsIBA 03/2014 - 08/2007
4	Azithromycin (Zithromax)FDA LinkGeneric 11/2022 - 11/2018
4	lumacaftorIBA 01/2019 - 01/2015
3	Biomarkers (Surrogate Marker)IBA 11/2015 - 04/2007
3	Tobramycin (Nebcin)FDA LinkGeneric 03/2014 - 07/2002
2	Proteins (Proteins, Gene)FDA Link 10/2015 - 01/2013
2	denufosol tetrasodiumIBA 03/2011 - 08/2007
1	C-Reactive ProteinIBA 11/2022
1	Peroxidase (Myeloperoxidase)IBA 11/2022
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 11/2022
1	tezacaftorIBA 11/2019
1	AnionsIBA 04/2019
1	VX-659IBA 10/2018
1	EnzymesIBA 01/2018
1	Amyloid (Amyloid Fibrils)IBA 01/2018
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2017
1	FatsIBA 03/2016
1	Ibuprofen (Motrin)FDA LinkGeneric 11/2015
1	pyoverdinIBA 08/2014
1	Peptide Hydrolases (Proteases)FDA Link 08/2014
1	Adrenergic Agents (Adrenergic Drugs)IBA 07/2014
1	neodymium pyrocatechin disulfonate (NPD)IBA 03/2014
1	Gentamicins (Gentamicin)FDA LinkGeneric 03/2014
1	PowdersIBA 03/2014
1	Ceftazidime (Fortum)FDA LinkGeneric 03/2014
1	Amphotericin B (Amphotericin)FDA LinkGeneric 03/2014
1	Amikacin (A.M.K)FDA LinkGeneric 03/2014
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 08/2013
1	ElementsIBA 10/2012
1	Ion Channels (Ion Channel)IBA 03/2011
1	SodiumIBA 03/2011
1	Glucose (Dextrose)FDA LinkGeneric 11/2010
1	Interleukin-8 (Interleukin 8)IBA 02/2009
1	Leukocyte Elastase (Neutrophil Elastase)IBA 02/2009
1	ExotoxinsIBA 02/2009
1	SolutionsIBA 07/2007
1	AminoglycosidesIBA 12/2006
1	Virulence Factors (Pathogenicity Factors)IBA 05/2006
1	chironIBA 07/2002

Therapy/Procedure

19	Therapeutics 01/2022 - 10/2003
3	Enzyme Replacement Therapy 01/2022 - 08/2013
1	Ambulatory Care (Outpatient Care) 01/2017
1	Injections 03/2014
1	Duration of Therapy 07/2007
1	Catheters 12/2006
1	Nebulizers and Vaporizers (Inhaler) 07/2002